155 related articles for article (PubMed ID: 6249713)
1. The problems of poliovirus immunization.
Fulginiti VA
Hosp Pract; 1980 Aug; 15(8):61-7. PubMed ID: 6249713
[No Abstract] [Full Text] [Related]
2. [Poliomyelitis vaccination in Denmark].
Petersen I
Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
[No Abstract] [Full Text] [Related]
3. Poliomyelitis vaccines in Belgium: 20 years of experience.
Andre FE
Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
[No Abstract] [Full Text] [Related]
4. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
Goldblum N; Kra-Oz Z; Swartz T
Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
[TBL] [Abstract][Full Text] [Related]
5. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
Zabicka J
Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
[No Abstract] [Full Text] [Related]
6. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V; Kyriakopoulou Z; Markoulatos P
Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
[TBL] [Abstract][Full Text] [Related]
7. Criteria for control of infectious diseases with poliomyelitis as an example.
Evans AS
Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
[No Abstract] [Full Text] [Related]
8. Poliovirus vaccines: live or dead.
Ogra PL; Faden HS
J Pediatr; 1986 Jun; 108(6):1031-3. PubMed ID: 3712146
[No Abstract] [Full Text] [Related]
9. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
Salk J
Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
[TBL] [Abstract][Full Text] [Related]
10. Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants.
Slomski A
JAMA; 2023 Jan; 329(4):279. PubMed ID: 36692562
[No Abstract] [Full Text] [Related]
11. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-derived poliovirus cases exceed wild types.
Burki T
Lancet Infect Dis; 2019 Feb; 19(2):140. PubMed ID: 31876508
[No Abstract] [Full Text] [Related]
13. [Immunization and decrease in mortality of acute poliomyelitis].
Laflor Carot V; Bernalte Benazet A; Carpio JM; Cornejo JA
Rev Enferm; 1984 Jun; 7(70):22-30. PubMed ID: 6566431
[No Abstract] [Full Text] [Related]
14. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.
Wkly Epidemiol Rec; 2010 Jun; 85(23):213-28. PubMed ID: 20545051
[No Abstract] [Full Text] [Related]
15. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
16. Current poliomyelitis immunization policy in the United States.
Sutter RW; Onorato IM; Patriarca PA
Pediatr Ann; 1990 Dec; 19(12):702-6. PubMed ID: 2177873
[No Abstract] [Full Text] [Related]
17. [Will Salk's polio vaccination be used again?].
Stickl H
Fortschr Med; 1978 Apr; 96(13):688-94. PubMed ID: 631710
[TBL] [Abstract][Full Text] [Related]
18. [Poliomyelitis immunization].
Vivell O
Landarzt; 1967 May; 43(15):716-20. PubMed ID: 4305217
[No Abstract] [Full Text] [Related]
19. Killed polio virus vaccine in the control of poliomyelitis in Finland.
Lapinleimu K
Ann Clin Res; 1982 Dec; 14(5-6):199-203. PubMed ID: 6303196
[No Abstract] [Full Text] [Related]
20. Change from oral poliovirus vaccine to inactivated poliovirus vaccine.
Mele A; Jefferson T; Franco E; Salmaso S
Lancet; 2002 Oct; 360(9340):1178. PubMed ID: 12387987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
